صفحه 1 از جانب 52 نتایج
FIELD OF THE INVENTION
This invention relates to a group of novel compositions containing diphenylhydantoin and/or dextromethorphan or another compound that binds to the same sites in the brain as dextromethorphan, with substantially the same or higher affinity. Another aspect of this invention
FIELD OF THE INVENTION
The present invention relates to compounds useful in treating pathological conditions, such as convulsions and spasticity, without producing undesirable excessive sedation or muscle weakness in animal subjects, including humans. More particularly, the invention relates to the
FIELD OF THE INVENTION
The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains
FIELD OF THE INVENTION
The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains
FIELD OF THE INVENTION
The present invention relates to a method of convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains about 370 mg
FIELD OF THE INVENTION
The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds.
BACKGROUND OF THE INVENTION
Copper is a normal component of the human brain, which contains
BACKGROUND OF THE INVENTION
The present invention relates to certain novel imidazo[4,5-b]pyridines useful as anxiolytic and anticonvulsant agents, by virtue of their ability to bind to the benzodiazepine receptors and inhibit electrically or chemically induced seizures.
The preparation of fused
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is filed under the provisions of 35 U.S.C. .sctn.371 and claims the priority of International Patent Application No. PCT/ES2009/070201 filed on 3 Jun. 2009 entitled "Use of Statins as Anticonvulsants, Antiepileptics and Neuroprotectors" in the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to new anticonvulsants drugs and pharmaceutical compositions containing the anticonvulsants drugs and methods of treating with the drugs.
2. Description of Related Art
GABA is an inhibitory neurotransmitter which
FIELD OF THE INVENTION
This invention pertains to a group of compounds which exhibit surprising anticonvulsant and neuroprotective properties, and methods for their use in controlling seizures or convulsions. The compounds are 1-phenylalkanecarboxylic acid derivatives. The invention is also directed
More specifically this invention relates to compounds of the formula ##STR1## and the tautomers thereof, wherein
R.sub.1 is hydrogen of C.sub.1-4 lower alkyl,
R.sub.2 is C.sub.1-4 lower alkyl,
R is halogeno or trifluoromethyl, and n is zero, 1 or 2.
For R, preferably halogeno represents chloro or
This invention relates to the use as anticonvulsant agents for the treatment of seizure disorders of 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones.
More specifically this invention relates to compounds of the formula ##STR1## and the tautomers thereof, wherein R.sub.1 is hydrogen or
BACKGROUND OF THE INVENTION
1. Technical Field
This invention pertains to a group of novel compounds which exhibit anticonvulsant and neuroprotective properties, methods for their use in controlling seizures or convulsions, and methods of preparing these compounds. The novel compounds of the
CROSS REFERENCE TO RELATED APPLICATION
The present application is related to a co-pending application entitled DEXTRORPHAN POTENTIATOR FOR ANTICONVULSANT COMPOSITIONS AND METHOD, Ser. No. 136,564 filed concurrently herewith.
BACKGROUND OF THE INVENTION
1. Field Of The Invention
The present invention
FIELD OF THE INVENTION
This invention relates to novel anticonvulsant aminoalkylpyridine (AAP) optical stereoisomers of enantiomers and their specific method of preparation. More particularly it relates to novel (+) AAP enantiomers that are more selective in their anticonvulsant action than the